170 related articles for article (PubMed ID: 30425469)
1. Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers.
Mariotti F; Govoni M; Lucci G; Santoro D; Nandeuil MA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3399-3410. PubMed ID: 30425469
[TBL] [Abstract][Full Text] [Related]
2. A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients.
Singh D; Leaker B; Boyce M; Nandeuil MA; Collarini S; Mariotti F; Santoro D; Barnes PJ
Pulm Pharmacol Ther; 2016 Oct; 40():1-6. PubMed ID: 27373438
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers.
Ferrari A; Compagnoni A; Nandeuil A; Maison-Blanche P
J Cardiovasc Pharmacol; 2016 Jul; 68(1):41-8. PubMed ID: 26945156
[TBL] [Abstract][Full Text] [Related]
4. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Singh D; Beeh KM; Colgan B; Kornmann O; Leaker B; Watz H; Lucci G; Geraci S; Emirova A; Govoni M; Nandeuil MA
Respir Res; 2019 Aug; 20(1):180. PubMed ID: 31399091
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
Singh D; Emirova A; Francisco C; Santoro D; Govoni M; Nandeuil MA
Respir Res; 2020 Sep; 21(1):246. PubMed ID: 32962709
[TBL] [Abstract][Full Text] [Related]
6. Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects.
Wilson R; Jarvis E; Montembault M; Hamblin JN; Hessel EM; Cahn A
Clin Ther; 2018 Aug; 40(8):1410-1417. PubMed ID: 30055824
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology.
Fioni A; Selg E; Cenacchi V; Acevedo F; Brogin G; Gerde P; Puccini P
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):61-70. PubMed ID: 28768120
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects.
Ino H; Wilson R; Terao T; Ogura H; Igarashi H; Cahn A; Numachi Y
Clin Pharmacol Drug Dev; 2019 Jan; 8(1):78-86. PubMed ID: 30303626
[TBL] [Abstract][Full Text] [Related]
9. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
LaForce C; Alexander M; Deckelmann R; Fabbri LM; Aisanov Z; Cameron R; Owen R; Higgins M
Allergy; 2008 Jan; 63(1):103-11. PubMed ID: 18053019
[TBL] [Abstract][Full Text] [Related]
10. Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).
Beeh KM; Emirova A; Prunier H; Santoro D; Nandeuil MA
Int J Chron Obstruct Pulmon Dis; 2018; 13():1701-1711. PubMed ID: 29872288
[TBL] [Abstract][Full Text] [Related]
11. The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants.
Li W; Daoud SZ; Trivedi R; Lukka PB; Jimenez E; Molins E; Stewart C; Bharali P; Garcia-Gil E
Int J Chron Obstruct Pulmon Dis; 2023; 18():2725-2735. PubMed ID: 38046981
[TBL] [Abstract][Full Text] [Related]
12. CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window.
Villetti G; Carnini C; Battipaglia L; Preynat L; Bolzoni PT; Bassani F; Caruso P; Bergamaschi M; Pisano AR; Puviani V; Stellari FF; Cenacchi V; Volta R; Bertacche V; Mileo V; Bagnacani V; Moretti E; Puccini P; Catinella S; Facchinetti F; Sala A; Civelli M
J Pharmacol Exp Ther; 2015 Mar; 352(3):568-78. PubMed ID: 25576073
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma.
Pearlman DS; Greos L; LaForce C; Orevillo CJ; Owen R; Higgins M
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):90-5. PubMed ID: 18681090
[TBL] [Abstract][Full Text] [Related]
14. A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects.
Cheung D; Fong A; Ding HT; Cabanski CR; Wang J; Chen Y; Bush J; Harris JM; Pan L
Pulm Pharmacol Ther; 2021 Aug; 69():102051. PubMed ID: 34166834
[TBL] [Abstract][Full Text] [Related]
15. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
Chuchalin AG; Manjra AI; Rozinova NN; Skopková O; Cioppa GD; Till D; Kaiser G; Fashola T; Kottakis J
J Aerosol Med; 2005; 18(1):63-73. PubMed ID: 15741775
[TBL] [Abstract][Full Text] [Related]
16. Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.
Singh D; Lea S; Mathioudakis AG
Drugs; 2021 Nov; 81(16):1821-1830. PubMed ID: 34731461
[TBL] [Abstract][Full Text] [Related]
17. A novel model-based approach for dose determination of glycopyrronium bromide in COPD.
Arievich H; Overend T; Renard D; Gibbs M; Alagappan V; Looby M; Banerji D
BMC Pulm Med; 2012 Dec; 12():74. PubMed ID: 23217058
[TBL] [Abstract][Full Text] [Related]
18. Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies.
Fuertig R; Goettel M; Herich L; Hoefler J; Wiebe ST; Sharma V
CNS Drugs; 2023 Dec; 37(12):1081-1097. PubMed ID: 38019355
[TBL] [Abstract][Full Text] [Related]
19. Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Govoni M; Bassi M; Vezzoli S; Lucci G; Emirova A; Nandeuil MA; Petruzzelli S; Jellema GL; Afolabi EK; Colgan B; Leaker B; Kornmann O; Beeh KM; Watz H; Singh D
Respir Res; 2020 Mar; 21(1):72. PubMed ID: 32197620
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
